Author

Johanna C Escher 1

1 Erasmus MC - Sophia Children's Hospital,Rotterdam,Netherlands

A 12-WEEK TAILORED PHYSICAL TRAINING PROGRAM INCLUDING DIETARY ADVICE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A RANDOMIZED CROSSOVER TRIAL​​​​.

Linda Elisabeth Scheffers, Johanna C Escher, Linda Elisabeth van den Berg, Mariëlle W Pijnenburg, Wim A Helbing, E.M. Utens, G.C. Dielemans, A.T. Ploeg

CIRCULATING INFLAMMATORY PROTEIN AND CELLULAR PROFILES AT TIME OF DIAGNOSIS CLASSIFY INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO THEIR UNDERLYING IMMUNE RESPONSE AND CLINICAL DISEASE COURSE

Maud Heredia, Mohammed Charrout, Martine Aardoom, Maria Myrthe Elisabeth Jongsma, Renz Klomberg, Polychronis Kemos, Daniëlle H. van Haaften, Bastiaan Tuk, Lisette A. van Berkel, Brenda Bley Folly, Ahmed Mahfouz, Marcel Reinders, Nick Croft, Johanna C Escher, Lissy de Ridder, Frank Ruemmele, Janneke N Samsom

CLINICAL RESPONSE TO TREATMENT, DISEASE PHENOTYPE AND SEROLOGY COMBINED ARE STRONG PREDICTORS OF THE NEED FOR SURGERY IN CHILDREN WITH CROHN'S DISEASE TWO YEARS AFTER DIAGNOSIS: RESULTS FROM THE PROSPECTIVE MULTICENTRE GROWTH STUDY

Arie Levine, Neil Chanchlani, Tomer Ziv-Baran, Johanna C Escher, Jorge Amil Dias, Gabor Veres, Sibylle Koletzko, Dan Turner, Kaija-Leena Kolho, Anders Paerregaard, Annamaria Staiano, Paolo Lionetti, Federica Nuti, Malgorata Sladek, Ron Shaoul, Javier Martín de Carpi, Rotem Boneh, Noa Cohen-Dolev, Tamar Pfeffer Gik, Richa

ELEVATED ADAPTIVE IMMUNE RESPONSES TO MULTIPLE LACHNOSPIRACEAE BACTERIAL FLAGELLINS IN THERAPY-NAIVE PEDIATRIC CD PATIENTS ARE ASSOCIATED WITH DISTINCT IMMUNE PATHOLOGY

Daniëlle M. H. Barendregt, M. E. Joosse, Katie L. Alexander, Léa M. M. Costes, Irma Tindemans, Ytje Simons-Oosterhuis, Martine Aardoom, Renz Klomberg, Maud Heredia, Danielle H. Hulleman - van Haaften, Bastiaan Tuk, Sandrine Nugteren, Michail Doukas, Johanna C. Escher, Lissy de Ridder, Charles O. Elson, Janneke N Samsom

LOW FREQUENCIES OF CIRCULATING INHIBITORY TIGIT+CD38+ EFFECTOR T CELLS IDENTIFY AN IMMUNOLOGICALLY DISTINCT SUBGROUP OF PEDIATRIC PATIENTS WITH SEVERE CROHN’S DISEASE

Maud Heredia, Léa Marie Mathilde Costes, Irma Tindemans, Polychronis Kemos, Maria E. Joosse, Martine Aardoom, Renz Klomberg, Daniëlle H. van Haaften, Bastiaan Tuk, Nick Croft, Frank Ruemmele, Johanna C Escher, Lissy de Ridder, Janneke N Samsom

SERUM INFLAMMATORY PROTEIN PROFILING TO CORROBORATE SELECTION OF THERAPY NAÏVE MODERATE-TO-SEVERE PAEDIATRIC CROHN’S DISEASE PATIENTS ELIGIBLE FOR FIRST-LINE INFLIXIMAB

Maria Myrthe Elisabeth Jongsma, Irma Tindemans, Lea M. M. Costes, Martinus A. Cozijnsen, H.C. Raatgeep, Merel van Pieterson, Yunlei Li, Lissy de Ridder, Johanna C Escher, Janneke N Samsom

Item 1 - 6 / 6
1